|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8 EUR | -0.62% |
|
-0.62% | 0.00% |
| 05-10 | Mib rises above 34,500; Iveco leads rises | AN |
| 05-09 | Svas Biosana increases revenues by single digits in first quarter | AN |
Svas Biosana S.p.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 118.28 million compared to EUR 97.23 million a year ago. Revenue was EUR 122.34 million compared to EUR 102.28 million a year ago.
Net income was EUR 5.12 million compared to EUR 3.57 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 47.23M | |
| -5.43% | 182B | |
| +4.30% | 114B | |
| -3.09% | 68.38B | |
| +5.86% | 52.46B | |
| +8.15% | 44.25B | |
| +7.52% | 43.55B | |
| +25.54% | 32.69B | |
| +17.85% | 26.73B | |
| +1.00% | 25.79B |
SVAS BIOSANA S.P.A. 
